GlobeStar Therapeutics Corp Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
GlobeStar Therapeutics Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q2 2024.
  • GlobeStar Therapeutics Corp Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 1.24B shares, a 42.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.24B +369M +42.3% Jun 30, 2024 10-Q 2024-10-11
Q1 2024 1.16B +382M +49% Mar 31, 2024 10-Q 2024-06-28
Q4 2023 1.05B +279M +36.3% Dec 31, 2023 10-Q 2024-03-12
Q3 2023 996M +274M +37.9% Sep 30, 2023 10-Q 2024-10-11
Q2 2023 872M +188M +27.5% Jun 30, 2023 10-Q 2023-08-17
Q1 2023 780M +175M +28.8% Mar 31, 2023 10-Q 2023-05-31
Q4 2022 770M +170M +28.3% Dec 31, 2022 10-Q 2023-02-13
Q3 2022 722M +161M +28.6% Sep 30, 2022 10-K 2024-01-19
Q2 2022 684M +208M +43.5% Jun 30, 2022 10-Q/A 2022-08-23
Q1 2022 606M +130M +27.4% Mar 31, 2022 10-Q 2022-06-01
Q4 2021 600M +145M +31.8% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 561M +125M +28.7% Sep 30, 2021 10-K 2023-01-09
Q2 2021 477M +93.7M +24.5% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 476M +171M +56.3% Mar 31, 2021 10-Q 2021-05-21
Q4 2020 455M +245M +117% Dec 31, 2020 10-Q 2021-01-28
Q3 2020 436M +266M +156% Sep 30, 2020 10-K 2022-01-05
Q2 2020 383M +274M +252% Jun 30, 2020 10-Q 2020-07-14
Q1 2020 304M +204M +204% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 210M +125M +147% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 170M +101M +146% Sep 30, 2019 10-K 2020-12-03
Q2 2019 109M +48.2M +79.5% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 100M +45.7M +83.6% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 85.1M +33M +63.4% Dec 31, 2018 10-Q 2019-02-19
Q3 2018 69.3M +23.7M +52.1% Sep 30, 2018 10-K 2019-12-31
Q2 2018 60.6M +19.5M +47.6% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 54.6M +16M +41.5% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 52.1M +14.8M +39.7% Dec 31, 2017 10-Q 2018-02-15
Q3 2017 45.6M +12.1M +36% Sep 30, 2017 10-K 2019-01-03
Q2 2017 41.1M +9.56M +30.3% Jun 30, 2017 10-Q/A 2017-08-23
Q1 2017 38.6M +28.6M +285% Mar 31, 2017 10-Q 2017-05-19
Q4 2016 37.3M +27.5M +283% Dec 31, 2016 10-Q 2017-04-10
Q3 2016 33.5M +24.7M +281% Sep 30, 2016 10-K 2018-01-16
Q2 2016 31.5M +31.1M +8403% Jun 30, 2016 10-Q/A 2016-09-16
Q1 2016 10M -23.7M -70.3% Mar 31, 2016 10-Q/A 2016-06-16
Q4 2015 9.74M -18.3M -65.2% Dec 31, 2015 10-Q 2016-02-22
Q3 2015 8.79M +8.54M +3332% Sep 30, 2015 10-Q/A 2016-06-16
Q2 2015 371K -20.4M -98.2% Jun 30, 2015 10-Q/A 2015-09-24
Q1 2015 33.7M +18.9M +128% Mar 31, 2015 10-Q/A 2015-09-17
Q4 2014 28M +14.9M +114% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 256K -10.6M -97.6% Sep 30, 2014 10-K/A 2016-01-22
Q2 2014 20.8M +11.5M +124% Jun 30, 2014 10-Q/A 2014-09-04
Q1 2014 14.8M +6.28M +73.5% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 13.1M +6.92M +112% Dec 31, 2013 10-Q/A 2014-02-21
Q3 2013 10.9M +5.22M +92.4% Sep 30, 2013 10-Q/A 2014-09-04
Q2 2013 9.26M -4.44M -32.4% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 8.54M -3.46M -28.9% Mar 31, 2013 10-Q/A 2013-05-16
Q4 2012 6.2M -5.8M -48.4% Dec 31, 2012 10-Q/A 2013-03-07
Q3 2012 5.65M +5.05M +841% Sep 30, 2012 10-K/A 2014-01-23
Q2 2012 13.7M +1.7M +14.2% Jun 30, 2012 10-Q/A 2012-09-20
Q1 2012 12M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 12M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 600K -8.4M -93.3% Sep 30, 2011 10-K/A 2013-03-07
Q2 2011 12M Jun 30, 2011 10-Q 2011-08-11
Q3 2010 9M Sep 30, 2010 10-K 2011-12-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.